Mr Bill Little

Mr Bill Little

Medical Device Company

Orchestra BioMed

USA USA

Bill Little is Executive Vice President, Corporate Development and Strategy at Orchestra BioMed (Nasdaq: OBIO).

Bill Little is Executive Vice President, Corporate Development and Strategy at Orchestra BioMed (Nasdaq: OBIO), joining after serving as COO of Neovasc, which was acquired by Shockwave Medical. His leadership spans interventional cardiology and structural heart disease, with prior roles as Divisional VP of Global Marketing at Abbott Vascular, VP of Global Cardiovascular Therapies at St. Jude Medical, VP of Global Marketing at Bard Peripheral Vascular, and 13 years at Boston Scientific. He chairs Medyria’s board, serves on NuevoSono’s board, and previously sat on SpectraWAVE’s board before its January 2026 sale to Philips.

SPEAKER